TFAP2A and neoplasm: Similar results were obtained in CT26 mouse models, Tfap2a slowed tumor progression (Fig. S5A–D) and decreased Pdl1 expression accompanied by increased Cd8+ T cells and effector molecules in CT26 tumor tissues (Fig. S5E, F).